Liabilities Breakdown
18.5 M
Total Liabilities
Long-Term Liabilities
| Total Liabilities | 18.49 Million | |
| Current Liabilities | 20.24 Million | |
| Long-Term Liabilities | 1.13 Million | |
| Tax Liabilities | 382,825 |
How much will InflaRx NV owe in January?
 | By Raphi Shpitalnik | Macroaxis Story |
The stock experiences above-average trading activities. InflaRx NV Current Assets are fairly stable at the moment as compared to the past year. InflaRx NV reported Current Assets of 95.68 Million in 2021. Assets Non Current is likely to rise to about 31.8 M in 2022, whereas Average Assets are likely to drop slightly above 130.6 M in 2022. As many millenniums are trying to avoid biotechnology space, it makes sense to break down InflaRx NV a little further and try to understand its current market patterns.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Vlad Skutelnik
This firm currently holds 1.54 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest InflaRx NV is not taking enough advantage from borrowing. The company has a current ratio of 9.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist InflaRx NV until it has trouble settling it off, either with new capital or with free cash flow. So, InflaRx NV's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like InflaRx NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for InflaRx to invest in growth at high rates of return. When we think about InflaRx NV's use of debt, we should always consider it together with cash and equity.InflaRx NV financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures the total debt position of InflaRx NV, including all of InflaRx NV's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of InflaRx NV assets, the company is considered highly leveraged. Understanding the composition and structure of overall InflaRx NV debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business is and if it is worth investing in it. Please read more on our technical analysis page.
Understanding InflaRx Total Debt
InflaRx NV liabilities are broken down into two parts on the balance sheet. These are short-term (or current) obligations and long-term debt. InflaRx NV has to fulfill its short-term liabilities in this reporting year and should be no more than 12 months old. Long-term debt, on the other hand, is anything beyond the 12-month payment timeframe. Common short-term liabilities found on InflaRx NV balance sheet include debt obligations and money owed to different InflaRx NV vendors, workers, and loan providers. Below is the chart of InflaRx main long-term debt accounts currently reported on its balance sheet. You can use InflaRx NV financial leverage analysis tool to get a better grip on understanding its financial positionHow important is InflaRx NV's Liquidity
InflaRx NV financial leverage refers to using borrowed capital as a funding source to finance InflaRx NV ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. InflaRx NV financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to InflaRx NV's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of InflaRx NV's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between InflaRx NV's total debt and its cash.
A Deeper Perspective
Net Loss for the year was (45.63 M) with profit before overhead, payroll, taxes, and interest of 0.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of InflaRx NV. Please refer to our Terms of Use for any information regarding our disclosure principles.